Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Significant condition. by Junxia Zhou (14381598)

Subjects:

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…<div><p>Hepatocellular carcinoma(HCC) has a high mortality and morbidity rate and seriously jeopardizes human life. …”

Results of significance for regression factors. by Junxia Zhou (14381598)

Subjects:

Soil partice-size distribution. by Yonggang Huang (223155)

“…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”

Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Decoding the Structure–Property–Function Relationships in Covalent Organic Frameworks for Sustainable Battery Design by Tarek M. Madkour (4921354)

Subjects:

Box plot show that there are no differences between different groups of the size of pus cavity. by Na Wang (193263)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

The diagram plots the volume of the “normal” IC (opposite to the ear with normal hearing <40dB loss; y-axis) as a function of the volume of the “deprived” IC (opposite to the ear w... by Pingling Kwok (14896191)

Subjects:

Particle size distribution of GO-GA NPs. by Huda H. Elbehery (22492996)

Subjects:

Fiber size and the VC. by Rie Asayama (693361)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Front and side images of the computer-aided design of the prostheses, including an interior perspective showing the location and size of the holes. by Long Li (6555)

Particle size distribution, PDI, and zeta potential of GO-GA NPs. by Huda H. Elbehery (22492996)

Subjects:

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects: